TY - JOUR
T1 - Comparison of early vascular morphological changes between bioresorbable poly-L-lactic acid scaffolds and metallic stents in porcine iliac arteries
AU - Sekimoto, Yasuhito
AU - Obara, Hideaki
AU - Matsubara, Kentaro
AU - Fujimura, Naoki
AU - Harada, Hirohisa
AU - Kitagawa, Yuko
N1 - Publisher Copyright:
© 2017 Taylor & Francis.
PY - 2017/4/3
Y1 - 2017/4/3
N2 - Bioresorbable scaffolds have the potential to overcome several problems associated with metallic stents. Bioresorbable poly-L-lactic acid (PLLA) scaffold implantation for the treatment of peripheral artery disease has already been reported in animal models and clinical trials; however, no studies comparing PLLA scaffolds and bare metal stents (BMSs) with regard to early vascular morphological changes, identified using intravascular ultrasound (IVUS) analysis, have been reported. In this study, PLLA scaffolds and BMSs were implanted bilaterally in iliac arteries of five miniature pigs. Digital subtraction angiography and IVUS were performed before and immediately after stent implantation and at 6-week follow-up. All PLLA scaffolds and BMSs were patent at 6-week follow-up. Per IVUS analysis, the percent area stenosis did not significantly differ between PLLA scaffolds and BMSs (65.7% vs. 67.2%, P =.761). Furthermore, percent vessel lumen change also did not differ significantly. Neointima formation (the neointimal area plus medial area) was significantly less with PLLA scaffolds than with BMSs (15.65 mm2 vs. 25.69 mm2, P <.001). In conclusion, based on IVUS results, short-term results after stent implantation in porcine iliac arteries were comparable between PLLA scaffolds and BMSs. Therefore, PLLA scaffolds are safe and feasible for implantation in peripheral arteries.
AB - Bioresorbable scaffolds have the potential to overcome several problems associated with metallic stents. Bioresorbable poly-L-lactic acid (PLLA) scaffold implantation for the treatment of peripheral artery disease has already been reported in animal models and clinical trials; however, no studies comparing PLLA scaffolds and bare metal stents (BMSs) with regard to early vascular morphological changes, identified using intravascular ultrasound (IVUS) analysis, have been reported. In this study, PLLA scaffolds and BMSs were implanted bilaterally in iliac arteries of five miniature pigs. Digital subtraction angiography and IVUS were performed before and immediately after stent implantation and at 6-week follow-up. All PLLA scaffolds and BMSs were patent at 6-week follow-up. Per IVUS analysis, the percent area stenosis did not significantly differ between PLLA scaffolds and BMSs (65.7% vs. 67.2%, P =.761). Furthermore, percent vessel lumen change also did not differ significantly. Neointima formation (the neointimal area plus medial area) was significantly less with PLLA scaffolds than with BMSs (15.65 mm2 vs. 25.69 mm2, P <.001). In conclusion, based on IVUS results, short-term results after stent implantation in porcine iliac arteries were comparable between PLLA scaffolds and BMSs. Therefore, PLLA scaffolds are safe and feasible for implantation in peripheral arteries.
KW - Igaki-Tamai stent
KW - bioresorbable scaffold
KW - intravascular ultrasound
KW - neointima formation
KW - peripheral artery disease
KW - poly-L-lactic acid
UR - http://www.scopus.com/inward/record.url?scp=85011805306&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85011805306&partnerID=8YFLogxK
U2 - 10.1080/15476278.2017.1280211
DO - 10.1080/15476278.2017.1280211
M3 - Article
C2 - 28102777
AN - SCOPUS:85011805306
SN - 1547-6278
VL - 13
SP - 29
EP - 38
JO - Organogenesis
JF - Organogenesis
IS - 2
ER -